Phytonix
Black Mountain, US · 1 known investors
Phytonix is an industrial biotechnology company that uses genetically engineered cyanobacteria and synthetic biology to convert carbon dioxide emissions and sunlight into sustainable chemicals and fuels, starting with n-butanol as a drop-in gasoline replacement and industrial chemical. It targets the global n-butanol chemical market and co-locates its production with industrial CO2 emitters.
BiotechCleantechClimate TechEnergy
Founders & leadership
BD
Bruce DannenbergFounder
MW
Michael WeedonNamed on SEC filing
Investors · 1
Competitors · 3
by search overlapTonix Pharmaceuticals Holding5 shared keywordsTonix is a biotechnology company developing therapies for chronic and complex conditions across central nervous system disorders, infectious diseases, immunology/immuno-oncology, and rare diseases. Its pipeline includes candidates for acute stress disorder, PTSD, smallpox/mpox vaccination, organ transplant rejection, and Prader-Willi syndrome.
Nanoionix4 shared keywordsNanoionix develops engineered materials designed to protect the environment and improve quality of life.
Cytonics4 shared keywordsCytonics develops A2M-based biologic therapies for osteoarthritis, including its lead candidate CYT-108, a "super A2M" drug in FDA clinical trials that targets enzymes responsible for cartilage degradation. The company aims to create the first disease-modifying therapy for osteoarthritis rather than treating only symptoms.
Companies competing with Phytonix for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 2 of 3 rounds · 2015–2021
▶$8KraisedAug 2021 · 1 investors · Other EnergyRule 506(b)
▶$8KraisedAug 2021 · 1 investors · Other Energy
Rule 506(b)Officers, directors & promoters on the filing
- Michael WeedonDirector
- Bruce DannenbergExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $8K
- Minimum investment
- $7K
- Proceeds to insiders
- $50K
- First sale
- Aug 2021
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$3MofferedSep 2019 · Other EnergyRule 506(b)
▶$3MofferedSep 2019 · Other Energy
Rule 506(b)Officers, directors & promoters on the filing
- Gordon Dennis SkeneExecutive Officer, Director
- William H CoryDirector
- Michael WeedonDirector
- Bruce DannenbergExecutive Officer, Director
- Rick HoppDirector
- Offering amount
- $3M
- Minimum investment
- $10K
- Proceeds to insiders
- $320K
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$3MraisedSep 2018 · 112 investors · Other EnergyRule 506(b)
▶$3MraisedSep 2018 · 112 investors · Other Energy
Rule 506(b)Officers, directors & promoters on the filing
- Rick HoppDirector
- Bruce DannenbergExecutive Officer, Director
- Michael WeedonDirector
- Gordon Dennis SkeneExecutive Officer, Director
- William H CoryDirector
- Offering amount
- $3.8M
- Amount sold
- $3M
- Minimum investment
- $10K
- Proceeds to insiders
- $896K
- First sale
- Feb 2015
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Phytonix do?
- Phytonix is an industrial biotechnology company that uses genetically engineered cyanobacteria and synthetic biology to convert carbon dioxide emissions and sunlight into sustainable chemicals and fuels, starting with n-butanol as a drop-in gasoline replacement and industrial chemical. It targets the global n-butanol chemical market and co-locates its production with industrial CO2 emitters.
- Who founded Phytonix?
- Phytonix was founded by Bruce Dannenberg.
- Who are Phytonix's investors?
- Phytonix's investors include Keiretsu Forum.
- How much funding has Phytonix raised?
- Phytonix has disclosed $3.1M raised across 2 of its 3 known rounds.
- Where is Phytonix headquartered?
- Phytonix is headquartered in Black Mountain, US.